English
簡(jiǎn)體中文Introduction to GeneSail Viral Vector Services
GenSail Biotech(Shanghai)Co., Ltd. now has
a total four thousand square meters international-competitive R&D base
which meets the requirements of GMP for tumor immunotherapy and gene therapy
vector. Our technology and management team has more than 20 years of research
and development experience in cancer, genetic diseases, and new generation
vaccines. We have expertise in engineering and developing a wide range of
recombinant viruses, including adenoviruses, herpes simplex virus and Vesicular Stomatitis Virus etc. We now offer viral vector design,
custom cloning and production services.
滬公網(wǎng)安備 31011502019914號